$MBVX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MABVAX THERAPEUTICS HOLDINGS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MABVAX THERAPEUTICS HOLDINGS, INC.. Get notifications about new insider transactions in MABVAX THERAPEUTICS HOLDINGS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | Barry Richard J. | 10% Owner | Buy | J | 0.76 | 100,000 | 76,000 | 11,999,418 | 11.9 M to 12 M (+0.84 %) |
Jun 14 2010 | MBVX | MABVAX THERAPEUTIC ... | CANTRALL EDWARD W | Director | Buy | P | 0.72 | 200 | 144 | 44,000 | 43.8 K to 44 K (+0.46 %) |
Jun 14 2010 | MBVX | MABVAX THERAPEUTIC ... | CANTRALL EDWARD W | Director | Buy | P | 0.71 | 400 | 284 | 43,800 | 43.4 K to 43.8 K (+0.92 %) |
Jun 14 2010 | MBVX | MABVAX THERAPEUTIC ... | CANTRALL EDWARD W | Director | Buy | P | 0.70 | 1,525 | 1,068 | 43,400 | 41.9 K to 43.4 K (+3.64 %) |
Jun 14 2010 | MBVX | MABVAX THERAPEUTIC ... | CANTRALL EDWARD W | Director | Buy | P | 0.73 | 6,475 | 4,727 | 41,875 | 35.4 K to 41.9 K (+18.29 %) |
Jun 14 2010 | MBVX | MABVAX THERAPEUTIC ... | CANTRALL EDWARD W | Director | Buy | P | 0.72 | 1,400 | 1,008 | 35,400 | 34 K to 35.4 K (+4.12 %) |
Jun 14 2010 | MBVX | MABVAX THERAPEUTIC ... | Barry Richard J. | 10% Owner | Buy | J | 0.72 | 500,000 | 360,000 | 11,899,418 | 11.4 M to 11.9 M (+4.39 %) |
May 12 2010 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | J | 0.00 | 10,317,291 | 0 | 1,532,709 | 11.9 M to 1.5 M (-87.07 %) |
Nov 18 2009 | MBVX | MABVAX THERAPEUTIC ... | Kaplan William Phillip | VP, General Counsel ... | Option Exercise | A | 0.79 | 125,000 | 98,750 | 125,000 | |
Nov 18 2009 | MBVX | MABVAX THERAPEUTIC ... | Steuer Marc | SVP - Business Deve ... | Option Exercise | A | 0.79 | 125,000 | 98,750 | 125,000 | |
Nov 18 2009 | MBVX | MABVAX THERAPEUTIC ... | BUTITTA CYNTHIA M | COO and CFO | Option Exercise | A | 0.79 | 350,000 | 276,500 | 350,000 | |
Nov 18 2009 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | A | 0.79 | 375,000 | 296,250 | 375,000 | |
Nov 18 2009 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | A | 0.79 | 550,000 | 434,500 | 550,000 | |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.81 | 300 | 244 | 7,971,542 | 8 M to 8 M (0.00 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.79 | 47,085 | 37,329 | 7,971,842 | 8 M to 8 M (-0.59 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.81 | 42,168 | 34,337 | 8,018,927 | 8.1 M to 8 M (-0.52 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.81 | 100,900 | 82,042 | 8,061,095 | 8.2 M to 8.1 M (-1.24 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.89 | 7,900 | 6,995 | 8,161,995 | 8.2 M to 8.2 M (-0.10 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.84 | 205,647 | 172,394 | 8,169,895 | 8.4 M to 8.2 M (-2.46 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.81 | 300 | 244 | 11,850,000 | 11.9 M to 11.9 M (0.00 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.79 | 47,085 | 37,329 | 11,850,300 | 11.9 M to 11.9 M (-0.40 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.81 | 42,168 | 34,337 | 11,897,385 | 11.9 M to 11.9 M (-0.35 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.81 | 100,900 | 82,042 | 11,939,553 | 12 M to 11.9 M (-0.84 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.89 | 7,900 | 6,995 | 12,040,453 | 12 M to 12 M (-0.07 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.84 | 205,647 | 172,394 | 12,048,353 | 12.3 M to 12 M (-1.68 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.99 | 5,366 | 5,298 | 8,375,542 | 8.4 M to 8.4 M (-0.06 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.96 | 68,205 | 65,136 | 8,380,908 | 8.4 M to 8.4 M (-0.81 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.90 | 70,559 | 63,277 | 8,449,113 | 8.5 M to 8.4 M (-0.83 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.86 | 718,477 | 618,321 | 8,519,672 | 9.2 M to 8.5 M (-7.78 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.99 | 110,253 | 109,095 | 9,238,149 | 9.3 M to 9.2 M (-1.18 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 0.99 | 16,400 | 16,190 | 9,348,402 | 9.4 M to 9.3 M (-0.18 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.99 | 5,900 | 5,825 | 12,254,000 | 12.3 M to 12.3 M (-0.05 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.96 | 75,000 | 71,625 | 12,259,900 | 12.3 M to 12.3 M (-0.61 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.90 | 77,589 | 69,582 | 12,334,900 | 12.4 M to 12.3 M (-0.63 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.86 | 790,049 | 679,916 | 12,412,489 | 13.2 M to 12.4 M (-5.98 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.99 | 110,253 | 109,095 | 13,202,538 | 13.3 M to 13.2 M (-0.83 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.99 | 16,400 | 16,190 | 13,312,791 | 13.3 M to 13.3 M (-0.12 %) |
Sep 18 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 1.19 | 15,800 | 18,725 | 9,364,802 | 9.4 M to 9.4 M (-0.17 %) |
Sep 18 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 1.20 | 25,300 | 30,264 | 9,380,602 | 9.4 M to 9.4 M (-0.27 %) |
Sep 18 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 1.20 | 104,709 | 125,159 | 9,405,902 | 9.5 M to 9.4 M (-1.10 %) |
Sep 18 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.19 | 15,800 | 18,725 | 13,329,191 | 13.3 M to 13.3 M (-0.12 %) |
Sep 18 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.20 | 25,300 | 30,264 | 13,344,991 | 13.4 M to 13.3 M (-0.19 %) |
Sep 18 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.20 | 104,709 | 125,159 | 13,370,291 | 13.5 M to 13.4 M (-0.78 %) |
May 22 2009 | MBVX | MABVAX THERAPEUTIC ... | von Morze Herwig | Director | Option Exercise | A | 0.52 | 10,000 | 5,200 | 10,000 | |
May 22 2009 | MBVX | MABVAX THERAPEUTIC ... | GOLDRING STEVEN R | Director | Option Exercise | A | 0.52 | 10,000 | 5,200 | 10,000 | |
May 22 2009 | MBVX | MABVAX THERAPEUTIC ... | NEWMAN RICHARD B | Director | Option Exercise | A | 0.52 | 10,000 | 5,200 | 10,000 | |
May 22 2009 | MBVX | MABVAX THERAPEUTIC ... | CANTRALL EDWARD W | Director | Option Exercise | A | 0.52 | 10,000 | 5,200 | 10,000 | |
May 18 2009 | MBVX | MABVAX THERAPEUTIC ... | RYSER STEFAN | SVP, Corporate Stra ... | Sell | S | 0.54 | 4,779 | 2,581 | 0 | 4.8 K to 0 (-100.00 %) |
May 18 2009 | MBVX | MABVAX THERAPEUTIC ... | RYSER STEFAN | SVP, Corporate Stra ... | Sell | S | 0.63 | 2,000 | 1,260 | 4,779 | 6.8 K to 4.8 K (-29.50 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.44 | 90,427 | 40,222 | 9,490,487 | 9.4 M to 9.5 M (+0.96 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 8,188 | 3,726 | 9,400,060 | 9.4 M to 9.4 M (+0.09 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 8,564 | 3,897 | 9,391,872 | 9.4 M to 9.4 M (+0.09 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 10,748 | 4,890 | 9,383,308 | 9.4 M to 9.4 M (+0.11 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 19,654 | 8,943 | 9,372,560 | 9.4 M to 9.4 M (+0.21 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 642 | 292 | 9,352,906 | 9.4 M to 9.4 M (+0.01 %) |
Feb 17 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 20,124 | 9,156 | 9,510,611 | 9.5 M to 9.5 M (+0.21 %) |
Feb 17 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 27,422 | 12,477 | 13,475,000 | 13.4 M to 13.5 M (+0.20 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.44 | 126,202 | 56,135 | 13,447,578 | 13.3 M to 13.4 M (+0.95 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 10,990 | 5,000 | 13,321,376 | 13.3 M to 13.3 M (+0.08 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 11,492 | 5,229 | 13,310,386 | 13.3 M to 13.3 M (+0.09 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 15,040 | 6,843 | 13,298,894 | 13.3 M to 13.3 M (+0.11 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 27,500 | 12,513 | 13,283,854 | 13.3 M to 13.3 M (+0.21 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 900 | 410 | 13,256,354 | 13.3 M to 13.3 M (+0.01 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 9,310 | 4,236 | 9,352,264 | 9.3 M to 9.4 M (+0.10 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 11,776 | 5,358 | 9,342,954 | 9.3 M to 9.3 M (+0.13 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 1,878 | 854 | 9,331,178 | 9.3 M to 9.3 M (+0.02 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 8,775 | 3,993 | 9,329,300 | 9.3 M to 9.3 M (+0.09 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 13,757 | 6,259 | 13,255,454 | 13.2 M to 13.3 M (+0.10 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 17,403 | 7,918 | 13,241,697 | 13.2 M to 13.2 M (+0.13 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 2,400 | 1,092 | 13,224,294 | 13.2 M to 13.2 M (+0.02 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 11,217 | 5,104 | 13,221,894 | 13.2 M to 13.2 M (+0.08 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.48 | 1,925 | 914 | 9,320,525 | 9.3 M to 9.3 M (+0.02 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 4,090 | 1,888 | 9,318,600 | 9.3 M to 9.3 M (+0.04 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 25,252 | 11,490 | 9,314,510 | 9.3 M to 9.3 M (+0.27 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.48 | 15,133 | 7,188 | 9,289,258 | 9.3 M to 9.3 M (+0.16 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.48 | 1,058 | 503 | 9,274,125 | 9.3 M to 9.3 M (+0.01 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.48 | 2,400 | 1,140 | 13,210,677 | 13.2 M to 13.2 M (+0.02 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 5,100 | 2,354 | 13,208,277 | 13.2 M to 13.2 M (+0.04 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.48 | 511 | 243 | 13,203,177 | 13.2 M to 13.2 M (0.00 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 38,174 | 17,369 | 13,202,666 | 13.2 M to 13.2 M (+0.29 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.48 | 22,875 | 10,866 | 13,164,492 | 13.1 M to 13.2 M (+0.17 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.48 | 1,600 | 760 | 13,141,617 | 13.1 M to 13.1 M (+0.01 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.51 | 131,231 | 66,757 | 9,273,067 | 9.1 M to 9.3 M (+1.44 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.50 | 22,366 | 11,270 | 9,141,836 | 9.1 M to 9.1 M (+0.25 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.45 | 73,607 | 33,116 | 9,119,470 | 9 M to 9.1 M (+0.81 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 18,163 | 8,295 | 9,045,863 | 9 M to 9 M (+0.20 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.45 | 1,840 | 833 | 9,027,700 | 9 M to 9 M (+0.02 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.51 | 186,453 | 94,849 | 13,140,017 | 13 M to 13.1 M (+1.44 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.45 | 104,580 | 47,051 | 12,953,564 | 12.8 M to 13 M (+0.81 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.50 | 31,776 | 16,012 | 12,848,984 | 12.8 M to 12.8 M (+0.25 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 26,847 | 12,261 | 12,817,208 | 12.8 M to 12.8 M (+0.21 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.45 | 2,719 | 1,230 | 12,790,361 | 12.8 M to 12.8 M (+0.02 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.46 | 48,405 | 22,291 | 9,025,860 | 9 M to 9 M (+0.54 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.45 | 14,096 | 6,393 | 8,977,455 | 9 M to 9 M (+0.16 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.40 | 2,878 | 1,137 | 8,963,359 | 9 M to 9 M (+0.03 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.40 | 26,103 | 10,311 | 8,960,481 | 8.9 M to 9 M (+0.29 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 67,755 | 31,201 | 12,787,642 | 12.7 M to 12.8 M (+0.53 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.45 | 19,730 | 8,948 | 12,719,887 | 12.7 M to 12.7 M (+0.16 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.40 | 4,000 | 1,580 | 12,700,157 | 12.7 M to 12.7 M (+0.03 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.40 | 36,273 | 14,328 | 12,696,157 | 12.7 M to 12.7 M (+0.29 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.39 | 16,506 | 6,355 | 8,934,378 | 8.9 M to 8.9 M (+0.19 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.38 | 888 | 336 | 8,917,872 | 8.9 M to 8.9 M (+0.01 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.39 | 44,298 | 17,254 | 8,916,984 | 8.9 M to 8.9 M (+0.50 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.36 | 2,121 | 771 | 8,872,686 | 8.9 M to 8.9 M (+0.02 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.37 | 3,574 | 1,322 | 8,870,565 | 8.9 M to 8.9 M (+0.04 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.38 | 10,335 | 3,943 | 8,866,991 | 8.9 M to 8.9 M (+0.12 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.35 | 1,898 | 655 | 8,856,656 | 8.9 M to 8.9 M (+0.02 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.36 | 38,902 | 13,915 | 8,854,758 | 8.8 M to 8.9 M (+0.44 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.38 | 186,454 | 70,573 | 8,815,856 | 8.6 M to 8.8 M (+2.16 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.36 | 118,048 | 41,907 | 8,629,402 | 8.5 M to 8.6 M (+1.39 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.39 | 25,000 | 9,625 | 12,659,884 | 12.6 M to 12.7 M (+0.20 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.38 | 1,343 | 508 | 12,634,884 | 12.6 M to 12.6 M (+0.01 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.39 | 79,354 | 30,908 | 12,633,541 | 12.6 M to 12.6 M (+0.63 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.36 | 3,800 | 1,382 | 12,554,187 | 12.6 M to 12.6 M (+0.03 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.37 | 6,400 | 2,368 | 12,550,387 | 12.5 M to 12.6 M (+0.05 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.38 | 18,512 | 7,062 | 12,543,987 | 12.5 M to 12.5 M (+0.15 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.35 | 3,400 | 1,173 | 12,525,475 | 12.5 M to 12.5 M (+0.03 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.36 | 55,020 | 19,681 | 12,522,075 | 12.5 M to 12.5 M (+0.44 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.38 | 263,708 | 99,813 | 12,467,055 | 12.2 M to 12.5 M (+2.16 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.36 | 166,962 | 59,272 | 12,203,347 | 12 M to 12.2 M (+1.39 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.35 | 194,638 | 68,863 | 8,511,354 | 8.3 M to 8.5 M (+2.34 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.34 | 8,352 | 2,836 | 8,316,716 | 8.3 M to 8.3 M (+0.10 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.36 | 112,418 | 39,908 | 8,308,364 | 8.2 M to 8.3 M (+1.37 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.30 | 3,001 | 885 | 8,195,946 | 8.2 M to 8.2 M (+0.04 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.35 | 56,648 | 19,566 | 8,192,945 | 8.1 M to 8.2 M (+0.70 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 0.32 | 73,619 | 23,352 | 8,136,297 | 8.1 M to 8.1 M (+0.91 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.35 | 255,980 | 90,566 | 12,036,385 | 11.8 M to 12 M (+2.17 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.34 | 10,984 | 3,730 | 11,780,405 | 11.8 M to 11.8 M (+0.09 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.36 | 147,850 | 52,487 | 11,769,421 | 11.6 M to 11.8 M (+1.27 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.30 | 3,300 | 974 | 11,621,571 | 11.6 M to 11.6 M (+0.03 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.35 | 62,303 | 21,519 | 11,618,271 | 11.6 M to 11.6 M (+0.54 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.32 | 80,968 | 25,683 | 11,555,968 | 11.5 M to 11.6 M (+0.71 %) |
Dec 17 2008 | MBVX | MABVAX THERAPEUTIC ... | CANTRALL EDWARD W | Director | Buy | P | 0.28 | 20,000 | 5,600 | 34,000 | 14 K to 34 K (+142.86 %) |
Dec 05 2008 | MBVX | MABVAX THERAPEUTIC ... | von Morze Herwig | Director | Buy | P | 0.20 | 20,000 | 4,000 | 22,000 | 2 K to 22 K (+1,000.00 %) |
Sep 02 2008 | MBVX | MABVAX THERAPEUTIC ... | RYSER STEFAN | SVP, Corporate Stra ... | Option Exercise | A | 0.67 | 250,000 | 167,500 | 250,000 | |
May 22 2008 | MBVX | MABVAX THERAPEUTIC ... | GOLDRING STEVEN R | Director | Option Exercise | A | 2.03 | 10,000 | 20,300 | 10,000 | |
Jun 25 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.26 | 4,261,019 | 5,368,884 | 11,475,000 | 15.7 M to 11.5 M (-27.08 %) |
Jun 25 2008 | MBVX | MABVAX THERAPEUTIC ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 1.26 | 2,373,554 | 2,990,678 | 8,062,678 | 10.4 M to 8.1 M (-22.74 %) |
May 22 2008 | MBVX | MABVAX THERAPEUTIC ... | von Morze Herwig | Director | Option Exercise | A | 2.03 | 10,000 | 20,300 | 10,000 | |
May 22 2008 | MBVX | MABVAX THERAPEUTIC ... | GRAY MARY ANN | Director | Option Exercise | A | 2.03 | 10,000 | 20,300 | 10,000 | |
May 22 2008 | MBVX | MABVAX THERAPEUTIC ... | NEWMAN RICHARD B | Director | Option Exercise | A | 2.03 | 10,000 | 20,300 | 10,000 | |
May 22 2008 | MBVX | MABVAX THERAPEUTIC ... | FRICK ROBERT W | Director | Option Exercise | A | 2.03 | 10,000 | 20,300 | 10,000 | |
May 22 2008 | MBVX | MABVAX THERAPEUTIC ... | CANTRALL EDWARD W | Director | Option Exercise | A | 2.03 | 10,000 | 20,300 | 10,000 | |
May 22 2008 | MBVX | MABVAX THERAPEUTIC ... | RYSER STEFAN | Director | Option Exercise | A | 2.03 | 10,000 | 20,300 | 10,000 | |
May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | M | 1.60 | 33,125 | 53,000 | 0 | |
May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | M | 1.60 | 21,875 | 35,000 | 0 | |
May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.11 | 1,600 | 3,376 | 132,391 | 134 K to 132.4 K (-1.19 %) |
May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.12 | 10,000 | 21,200 | 133,991 | 144 K to 134 K (-6.94 %) |
May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.10 | 9,100 | 19,110 | 143,991 | 153.1 K to 144 K (-5.94 %) |
May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.09 | 400 | 836 | 153,091 | 153.5 K to 153.1 K (-0.26 %) |